WinstonWınston
Siemens Healthineers AG logo

Siemens Healthineers AG

SHL.DE
54
Medical - Devices · Healthcare
Also trades as: 0PMJ.L
Price
€39.17
-0.34 (-0.86%)
Market Cap
€43.84B
Exchange
Frankfurt Stock Exchange
Winston Score
54
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 10, 2026 · filings through Jun 30, 2026

Share count rising — dilution

+1.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 1.10B (2021) → 1.12B (2025)

Siemens Healthineers makes medical equipment and software used in hospitals and clinics around the world. Its main products include MRI machines, CT scanners, X-ray systems, and laboratory diagnostic tools that help doctors detect and treat diseases. The company also owns Varian, a leading maker of cancer radiation therapy systems, which it acquired in 2021.

The company earns money by selling large imaging machines, consumable lab supplies, software licenses, and long-term service contracts that keep equipment running. It operates globally, with strong presence in Europe, North America, and Asia, and generates roughly €22 billion in annual revenue. Siemens Healthineers benefits from high switching costs, since hospitals rarely replace installed equipment ecosystems, and from its deep integration into clinical workflows. The key growth driver is expanding its cancer care and diagnostics businesses in emerging markets, while the main risk is pricing pressure from lower-cost competitors, particularly Chinese manufacturers gaining share in Asia.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
42.5%
Healthy — 42.5% gross margin
Operating Margin
17.7%
Healthy — 17.7% operating margin
ROCE
3.0%
Weak — 3.0% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-0.9%
Shrinking sales (-0.9% YoY)
EPS YoY
+2.6%
Flat earnings

Single-digit earnings growth — steady but not exciting.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
137%
Turns 137% of profit into real cash
FCF Margin
9.6%
Modest free cash flow (9.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.76
Moderate — manageable debt (0.76)
Interest Cover
8.45x
Comfortably covers interest (8.4x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
19.8x
Fair value — P/E 19.8

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
+7.6
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (19.8 → 12.2)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.90%
Moderate income — 2.90% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+22.2%
Dividend growing fast (22.2% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial